CR8009A - Compuestos benzo[1,2,5] tiadiazoles - Google Patents
Compuestos benzo[1,2,5] tiadiazolesInfo
- Publication number
- CR8009A CR8009A CR8009A CR8009A CR8009A CR 8009 A CR8009 A CR 8009A CR 8009 A CR8009 A CR 8009A CR 8009 A CR8009 A CR 8009A CR 8009 A CR8009 A CR 8009A
- Authority
- CR
- Costa Rica
- Prior art keywords
- tiadiazoles
- benzo compounds
- compounds
- benzo
- cck2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Ciertos compuestos de amidofenil-sufanilamino- benzol[1,2,5]tiadiazole son moduladores CCK2 utiles en el tratamiento de enfermedades mediadas por CCK2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45863803P | 2003-03-28 | 2003-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8009A true CR8009A (es) | 2008-09-10 |
Family
ID=34115280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8009A CR8009A (es) | 2003-03-28 | 2005-09-28 | Compuestos benzo[1,2,5] tiadiazoles |
Country Status (20)
Country | Link |
---|---|
US (2) | US7241759B2 (es) |
EP (1) | EP1675837A2 (es) |
JP (1) | JP2006528241A (es) |
KR (1) | KR20050119666A (es) |
CN (1) | CN1829704A (es) |
AU (1) | AU2004261547A1 (es) |
BR (1) | BRPI0408899A (es) |
CA (1) | CA2520546A1 (es) |
CO (1) | CO5700819A2 (es) |
CR (1) | CR8009A (es) |
EC (1) | ECSP056057A (es) |
IS (1) | IS8042A (es) |
MX (1) | MXPA05010484A (es) |
NO (1) | NO20055002L (es) |
NZ (1) | NZ542491A (es) |
RS (1) | RS20050733A (es) |
RU (1) | RU2005133206A (es) |
UA (1) | UA82872C2 (es) |
WO (1) | WO2005012275A2 (es) |
ZA (1) | ZA200508732B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005085188A2 (en) * | 2004-03-02 | 2005-09-15 | Compass Pharmaceuticals Llc | Compounds and methods for anti-tumor therapy |
MX2007003623A (es) | 2004-09-24 | 2007-09-11 | Johnson & Johnson | Compuestos sulfonamida. |
US7599588B2 (en) * | 2005-11-22 | 2009-10-06 | Vascular Imaging Corporation | Optical imaging probe connector |
EP1795198A1 (en) * | 2005-12-09 | 2007-06-13 | Hubrecht Laboratorium | Treatment of Barret's esophagus |
WO2008124518A1 (en) * | 2007-04-03 | 2008-10-16 | Janssen Pharmaceutica N.V. | Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor |
EP2053052A1 (en) * | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide |
NZ597379A (en) * | 2009-06-29 | 2014-04-30 | Agios Pharmaceuticals Inc | Therapeutic compounds and compositions |
RU2532492C1 (ru) * | 2013-01-28 | 2014-11-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ эндоскопического лечения гастродуоденальных язв |
RU2693484C1 (ru) | 2013-11-22 | 2019-07-03 | СиЭль БАЙОСАЕНСИЗ ЭлЭлСи | Антагонисты гастрина для лечения и профилактики остеопороза |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
ATE248823T1 (de) * | 1996-12-10 | 2003-09-15 | Zeria Pharm Co Ltd | 1,5-benzodiazepinderivate |
US6458845B1 (en) * | 1999-06-24 | 2002-10-01 | Smithkline Beecham Corporation | Macrophage scavenger receptor antagonists |
GB0028702D0 (en) | 2000-11-24 | 2001-01-10 | Novartis Ag | Organic compounds |
JP2004529170A (ja) * | 2001-05-07 | 2004-09-24 | スミスクライン・ビーチャム・コーポレイション | スルホンアミド |
ITTO20020674A1 (it) | 2002-07-26 | 2004-01-26 | Rotta Research Lab | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
-
2004
- 2004-03-26 WO PCT/US2004/009589 patent/WO2005012275A2/en active Application Filing
- 2004-03-26 RU RU2005133206/04A patent/RU2005133206A/ru not_active Application Discontinuation
- 2004-03-26 US US10/811,292 patent/US7241759B2/en active Active
- 2004-03-26 BR BRPI0408899-9A patent/BRPI0408899A/pt not_active IP Right Cessation
- 2004-03-26 RS YUP-2005/0733A patent/RS20050733A/sr unknown
- 2004-03-26 UA UAA200509353A patent/UA82872C2/uk unknown
- 2004-03-26 JP JP2006532352A patent/JP2006528241A/ja not_active Withdrawn
- 2004-03-26 NZ NZ542491A patent/NZ542491A/en unknown
- 2004-03-26 CN CNA2004800144708A patent/CN1829704A/zh active Pending
- 2004-03-26 EP EP04785868A patent/EP1675837A2/en not_active Withdrawn
- 2004-03-26 MX MXPA05010484A patent/MXPA05010484A/es unknown
- 2004-03-26 KR KR1020057018397A patent/KR20050119666A/ko not_active Application Discontinuation
- 2004-03-26 AU AU2004261547A patent/AU2004261547A1/en not_active Abandoned
- 2004-03-26 CA CA002520546A patent/CA2520546A1/en not_active Abandoned
-
2005
- 2005-09-23 IS IS8042A patent/IS8042A/is unknown
- 2005-09-28 EC EC2005006057A patent/ECSP056057A/es unknown
- 2005-09-28 CR CR8009A patent/CR8009A/es unknown
- 2005-10-05 CO CO05100979A patent/CO5700819A2/es not_active Application Discontinuation
- 2005-10-27 ZA ZA200508732A patent/ZA200508732B/en unknown
- 2005-10-27 NO NO20055002A patent/NO20055002L/no not_active Application Discontinuation
-
2007
- 2007-07-10 US US11/775,535 patent/US7550492B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR20050119666A (ko) | 2005-12-21 |
RS20050733A (en) | 2007-06-04 |
WO2005012275A2 (en) | 2005-02-10 |
IS8042A (is) | 2005-09-23 |
UA82872C2 (en) | 2008-05-26 |
ECSP056057A (es) | 2006-01-27 |
JP2006528241A (ja) | 2006-12-14 |
NO20055002D0 (no) | 2005-10-27 |
CO5700819A2 (es) | 2006-11-30 |
BRPI0408899A (pt) | 2006-04-18 |
MXPA05010484A (es) | 2006-03-10 |
NO20055002L (no) | 2005-12-14 |
RU2005133206A (ru) | 2006-05-10 |
US20070276016A1 (en) | 2007-11-29 |
EP1675837A2 (en) | 2006-07-05 |
US7241759B2 (en) | 2007-07-10 |
AU2004261547A1 (en) | 2005-02-10 |
CA2520546A1 (en) | 2005-02-10 |
WO2005012275A3 (en) | 2006-05-11 |
NZ542491A (en) | 2009-04-30 |
CN1829704A (zh) | 2006-09-06 |
US20040224983A1 (en) | 2004-11-11 |
US7550492B2 (en) | 2009-06-23 |
ZA200508732B (en) | 2007-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP066355A (es) | Compuestos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida como moduladores de la colecistocinina 2 | |
ECSP056057A (es) | Compuestos de benzo[1,2,5]tiadiazole | |
ECSP077360A (es) | Compuestos sulfonamida | |
SV2005001973A (es) | Quinolinas utiles en el tratamiento de enfermedades cardiovasculares ref. wyth0090-504 (am101500) | |
NI200600094A (es) | Compuesto heterociclicos fusionados | |
SG149063A1 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
BRPI0414598A (pt) | indóis substituìdos | |
ECSP066549A (es) | Compuestos de pirazolilo e imidazolilo bicíclicos y usos de los mismos | |
TW200509892A (en) | Novel aminobenzophenone compounds | |
ATE417051T1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
HRP20051005A2 (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
DK1532131T3 (da) | Motilid-forbindelser | |
NO20060361L (no) | Nye cytotoxiske depsipeptider | |
ECSP044971A (es) | Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson | |
NO20032406L (no) | Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens | |
ATE460938T1 (de) | Morpholin-derivate zur verwendung als dopaminagonisten in der behandlung von u.a. sexueller dysfunktion | |
NO20053562L (no) | Nye aminobenzofenonforbindelser | |
ATE403660T1 (de) | Benzo 4,5 thieno 3,2-b pyran-2-on enthaltende duftstoffzusammensetzungen | |
BRPI0510407A (pt) | derivados de 3-amino-2-fenilpirrolidina | |
EP1436279B8 (en) | Chemical compounds | |
ATE437846T1 (de) | Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe | |
ATE423780T1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
BRPI0515383A (pt) | n-etil hidroxietilamina útil no tratamento de condições do snc | |
UY26836A1 (es) | Pirrolidinas 1,3-disustituidas y 1,3,3-trisustituidas como ligandos del receptor de histamina y sus aplicaciones terapéuticas |